⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ChemPartner and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
ChemPartner
↗Guangzhou, China
ChemPartner is a global, science-based Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) that provides integrated, end-to-end solutions for the pharmaceutical and biotechnology industries. The company supports the entire drug development lifecycle, from early-stage discovery chemistry and biology to preclinical development, CMC, and commercial manufacturing.
With over 20 years of experience, ChemPartner has evolved into a comprehensive research innovation engine. The company operates globally with major facilities in China and a growing presence in the United States, including a Center of Excellence in Watertown, Massachusetts, designed to enhance collaboration with the North American biopharma ecosystem.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:2000
Ownership:public
Status:operating
STOCK
Exchange:Shenzhen Stock Exchange
Ticker:300149
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:ChemPartner US Corporation
Key Partnerships:Global pharmaceutical and biotechnology companies (over 400 clients)
COMPETITION
Position:Challenger
Competitors:WuXi AppTec, Crown Bioscience, Charles River Laboratories
LEADERSHIP
Key Executives:
William Woo - Chairman and CEO
Scientific Founders:Michael Hui
LINKS
Website:chempartner.us
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ChemPartner. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.